Cargando…

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey

BACKGROUND: Despite controversy among experts regarding aducanumab's approval by the U.S. Food and Drug Administration, little is known about public opinion on this matter. METHODS: We conducted a representative survey of U.S. adults ages 35 and older to (1) determine opinions regarding aducanu...

Descripción completa

Detalles Bibliográficos
Autores principales: DiStefano, Michael J., Alexander, G. Caleb, Polsky, Daniel, Anderson, Gerard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177789/
https://www.ncbi.nlm.nih.gov/pubmed/35129210
http://dx.doi.org/10.1111/jgs.17692